Grayhawk Investment Strategies’s Pfizer PFE Stock Holding History

Grayhawk Investment Strategies’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$37.3K	Hold	1,472	–	–	0.08%	50
2024 Q4	$39.1K	Hold	1,472	–	–	0.07%	53
2024 Q3	$42.6K	Hold	1,472	–	–	0.07%	37
2024 Q2	$41.2K	Hold	1,472	–	–	0.19%	52
2024 Q1	$40.8K	Hold	1,472	–	–	0.04%	79
2023 Q4	$42.4K	Hold	1,472	–	–	0.02%	164
2023 Q3	$48.8K	Hold	1,472	–	–	0.03%	54
2023 Q2	$54K	Hold	1,472	–	–	0.04%	57
2023 Q1	$81K	Buy	1,472 +1,377	+1,449%	+$59.5K	0.04%	47
2022 Q4	$75.4K	Sell	95 -1,377	-94%	-$66K	0.06%	43
2022 Q3	$88K	Hold	1,472	–	–	0.06%	46
2022 Q2	$99K	Buy	+1,472	New	+$75K	0.04%	48

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Grayhawk Investment Strategies's PFE Position: Q1 2025 in Review

Grayhawk Investment Strategies held its Pfizer (PFE) position steady in Q1 2025 at 1,472 shares worth $37.3K. The position accounts for 0.08% of the portfolio, ranked #50.

Grayhawk Investment Strategies first reported a position in PFE in Q2 2022 and has held it in 12 quarters since. The position peaked at $99K in Q2 2022. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Grayhawk Investment Strategies held 1,472 shares of Pfizer worth $37.3K as of Q1 2025.
Grayhawk Investment Strategies left its Pfizer share count unchanged in Q1 2025.
Pfizer made up 0.08% of Grayhawk Investment Strategies's portfolio in Q1 2025, its #50 holding.
Grayhawk Investment Strategies first reported a position in Pfizer in Q2 2022 and has held it in 12 quarters since.
Grayhawk Investment Strategies's Pfizer position peaked at $99K in Q2 2022.
2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Grayhawk Investment Strategies's 13F filing for Q1 2025, filed 15 May 2025.